雷贝拉唑
埃索美拉唑
阿莫西林
内科学
幽门螺杆菌
医学
胃肠病学
不利影响
质子抑制剂泵
抗生素
微生物学
生物
作者
Wei‐Chen Tai,I‐Ting Wu,Hsin‐Ming Wang,Pao‐Yuan Huang,Chih‐Chien Yao,Cheng‐Kun Wu,Shih‐Cheng Yang,Chih‐Ming Liang,Ping‐I Hsu,Seng‐Kee Chuah
标识
DOI:10.1016/j.jmii.2024.02.009
摘要
High-dose dual therapy (HDDT) using proton-pump inhibitors (PPI) and amoxicillin attracted attention for its simplicity and lower adverse event profile. Besides, vonoprazan is not available worldwide. This real-world study aims to compare the efficacy of esomeprazole-based and rabeprazole-based HDDT regimens and to identify clinical factors influencing outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI